Khai thác sinh học cho vi sinh vật nội sinh và các sản phẩm thiên nhiên của chúng
Tóm tắt
Từ khóa
#vi sinh vật nội sinh #sản phẩm thiên nhiên #cộng sinh #kháng sinh #thuốc chống nấm #chất ức chế miễn dịch #hợp chất chống ung thư #phân lập #cấy vi sinh vật #tinh chế #đặc tính hóa #y học hiện đại #nông nghiệp #công nghiệpTài liệu tham khảo
Baker D. U. Mocek and C. Garr. 2000. Natural products vs. combinatorials: a case study p. 66-72. In S. K. Wrigley M. A. Hayes R. Thomas E. J. T. Chrystal and N. Nicholson (ed.) Biodiversity: new leads for pharmaceutical and agrochemical industries. The Royal Society of Chemistry Cambridge United Kingdom.
Bashyal, B., J. Y. Li, G. A. Strobel, and W. M. Hess. 1999. Seimatoantlerium nepalense, an endophytic taxol producing coelomycete from Himalayan yew (Taxus wallichiana). Mycotaxon72:33-42.
Bensky D. and A. Gamble. 1993. Chinese herbal medicine. Materia medica new ed. Eastland Press Inc. Seattle Wash.
Bills G. A. Dombrowski F. Pelaez J. Polishook and Z. An. 2002. Recent and future discoveries of pharmacologically active metabolites from tropical fungi p. 165-194. In R. Watling J. C. Frankland A. M. Ainsworth S. Issac and C. H. Robinson. (ed.) Tropical mycology: micromycetes vol. 2. CABI Publishing New York N.Y.
Borel, J. F., and Z. L. Kis. 1991. The discovery and development of cyclosporine. Transplant. Proc.23:1867-1874.
Brewer S. 2000. The relationship between natural products and synthetic chemistry in the discovery process p. 59-65. In S. K. Wrigley M. A. Hayes R. Thomas E. J. T. Chrystal and N. Nicholson (ed.) Biodiversity: new leads for pharmaceutical and agrochemical industries. The Royal Society of Chemistry Cambridge United Kingdom.
Buss T. and M. A. Hayes. 2000. Mushrooms microbes and medicines p. 75-85. In S. K. Wrigley M. A. Hayes R. Thomas E. J. T. Chrystal and N. Nicholson (ed.) Biodiversity: new leads for pharmaceutical and agrochemical industries. The Royal Society of Chemistry Cambridge United Kingdom.
Concepcion G. P. J. E. Lazaro and K. D. Hyde. 2001. Screening for bioactive novel compounds p. 93-130. In S. B. Pointing and K. D. Hyde (ed.) Bio-exploitation of filamentous fungi. Fungal Diversity Press Hong Kong Hong Kong.
Daisy, B., G. Strobel, D. Ezra, U. Castillo, G. Baird, and W. M. Hess. 2002. Muscodor vitigenus anam. sp. nov., an endophyte from Paullinia paullinioides. Mycotaxon84:39-50.
Demain A. L. 2000. Microbial natural products: a past with a future p. 3-16. In S. K. Wrigley M. A. Hayes R. Thomas E. J. T. Chrystal and N. Nicholson (ed.) Biodiversity: new leads for pharmaceutical and agrochemical industries. The Royal Society of Chemistry Cambridge United Kingdom.
Dreyfuss M. M. and I. H. Chapela. 1994. Potential of fungi in the discovery of novel low-molecular weight pharmaceuticals p. 49-80. In V. P. Gullo (ed.) The discovery of natural products with therapeutic potential. Butterworth-Heinemann London United Kingdom.
Grabley S. and R. Thiericke (ed.). 1999. Drug discovery from nature p. 3-33. Springer-Verlag. Berlin Germany.
Hawksworth, D. C., and A. Y. Rossman. 1987. Where are the undescribed fungi? Phytopathology87:888-891.
Hoffman, A., W. Khan, J. Worapong, G. Strobel, D. Griffin, B. Arbogast, D. Borofsky, R. B. Boone, L. Ning, P. Zheng, and L. Daley. 1998. Bioprospecting for taxol in angiosperm plant extracts. Spectroscopy13:22-32.
Horn, W. S., M. S. J. Simmonds, R. E. Schwartz, and W. M. Blaney. 1995. Phomopsichalasin, a novel antimicrobial agent from an endophytic Phomopsis sp. Tetrahedron14:3969-3978.
Isaacs J. 2002. Aboriginal food and herbal medicine. New Holland Press Sydney Australia.
Li, C., R. P. Johnson, and J. A. Porco. 2003. Total synthesis of the quinine epoxide dimer (+)-torreyanic acid: application of a biomimetic oxidation/electrocyclization/Diels-Alder dimerization cascade. J. Am. Chem. Soc.125:5059-5106.
Li, J. Y., R. S. Sidhu, E. Ford, W. M. Hess, and G. A. Strobel. 1998. The induction of taxol production in the endophytic fungus Periconia sp. from Torreya grandifolia. J. Ind. Microbiol.20:259-264.
Mittermeier R. A. N. Meyers P. R. Gil and C. G. Mittermeier. 1999. Hotspots: Earth's biologically richest and most endangered ecoregions. Toppan Printing Co. Tokyo Japan.
National Institutes of Health. 2001. NIAID global health research plan for HIV/AIDS malaria and tuberculosis. U.S. Department of Health and Human Services Bethesda Md.
Pulici, M., F. Sugawara, H. Koshino, J. Uzawa, S. Yoshida, E. Lobkovsky, and J. Clardy. 1996. Metabolites of endophytic fungi of Taxus brevifolia-the first highly functionalized humulane of fungal origin. J. Chem. Res. N.8:378-379.
Redell P. and V. Gordon. 2000. Lessons from nature: can ecology provide new leads in the search for novel bioactive chemicals from rainforests? p. 205-212. In S. K. Wrigley M. A. Hayes R. Thomas E. J. T. Chrystal and N. Nicholson (ed.) Biodiversity: new leads for pharmaceutical and agrochemical industries. The Royal Society of Chemistry. Cambridge United Kingdom.
Schutz B. 2001. Endophytic fungi: a source of novel biologically active secondary metabolites p. 20. In British Mycological Society international symposium proceedings: bioactive fungal metabolites—impact and exploitation. University of Wales Swansea Wales.
Strobel, G. A., A. Stierle, D. Stierle, and W. M. Hess. 1993. Taxomyces andreanae a proposed new taxon for a bulbilliferous hyphomycete associated with Pacific yew. Mycotaxon47:71-78.
Suffness M. 1995. Taxol science and applications. CRC Press Boca Raton Fla.
Walsh T. A. 1992. Inhibitors of β-glucan synthesis p. 349-373. In J. A. Sutcliffe and N. H. Georgopapadakou (ed.) Emerging targets in antibacterial and antifungal chemotherapy. Chapman & Hall London United Kingdom.
Worapong, J., G. A. Strobel, E. J. Ford, J. Y. Li, G. Baird, and W. M. Hess. 2001. Muscodor albus gen. et sp. nov., an endophyte from Cinnamomum zeylanicum. Mycotaxon79:67-79.
Worapong, J., G. A. Strobel, B. Daisy, U. Castillo, G. Baird, and W. M. Hess. 2002. Muscodor roseus anna. nov. an endophyte from Grevillea pteridifolia. Mycotaxon81:463-475.